Focus on State of the Art in Diagnostics of the Acute Coronary Syndrome1
Acute coronary syndrome: many doubts, some answers
Annals of Translational Medicine
2016;
4
(10)
:187
.
(25 May 2016)
High-density lipoprotein cholesterol values independently and inversely predict cardiac troponin T and I concentration
Annals of Translational Medicine
2016;
4
(10)
:188
.
(25 May 2016)
The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program
Annals of Translational Medicine
2016;
4
(10)
:189
.
(25 May 2016)
Lower mean corpuscular hemoglobin concentration is associated with poorer outcomes in intensive care unit admitted patients with acute myocardial infarction
Annals of Translational Medicine
2016;
4
(10)
:190
.
(25 May 2016)
The clinics of acute coronary syndrome
Annals of Translational Medicine
2016;
4
(10)
:191
.
(25 May 2016)
Genetics of the acute coronary syndrome
Annals of Translational Medicine
2016;
4
(10)
:192
.
(25 May 2016)
Diagnostic algorithms for acute coronary syndrome—is one better than another?
Annals of Translational Medicine
2016;
4
(10)
:193
.
(25 May 2016)
An historical approach to the diagnostic biomarkers of acute coronary syndrome
Annals of Translational Medicine
2016;
4
(10)
:194
.
(25 May 2016)
Big-data Clinical Trial Column2
Residuals and regression diagnostics: focusing on logistic regression
Annals of Translational Medicine
2016;
4
(10)
:195
.
(25 May 2016)
Case Report
The worst of both worlds-combined pulmonary fibrosis and emphysema syndrome
Annals of Translational Medicine
2016;
4
(10)
:196
.
(25 May 2016)
Laparoscopic Finney pyloroplasty in the emergency setting: first case report in the literature and technical challenges
Annals of Translational Medicine
2016;
4
(10)
:197
.
(25 May 2016)
Not all right-sided hearts are the same—the importance of identifying the correct diagnosis
Annals of Translational Medicine
2016;
4
(10)
:198
.
(25 May 2016)
Editorial
Editorial on low-dose acetylsalicylic acid treatment and impact on short-term mortality in Staphylococcus aureus bloodstream infection: a propensity score-matched cohort study
Annals of Translational Medicine
2016;
4
(10)
:199
.
(25 May 2016)
miRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients
Annals of Translational Medicine
2016;
4
(10)
:200
.
(25 May 2016)
Nivolumab for advanced non-small cell lung cancer: an immunologically-mediated tumor checkout
Annals of Translational Medicine
2016;
4
(10)
:201
.
(25 May 2016)
Does renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?
Annals of Translational Medicine
2016;
4
(10)
:202
.
(25 May 2016)
Perspective
Sarco“MiR” friend or foe: a perspective on the mechanisms of doxorubicin-induced cardiomyopathy
Annals of Translational Medicine
2016;
4
(10)
:203
.
(25 May 2016)
Engineered cell-free scaffold with two-stage delivery of miRNA-26a for bone repair
Annals of Translational Medicine
2016;
4
(10)
:204
.
(25 May 2016)
Commentary
Omission of systematic transrectal ultrasound guided biopsy from the MRI targeted approach in men with previous negative prostate biopsy might still be premature
Annals of Translational Medicine
2016;
4
(10)
:205
.
(25 May 2016)
Heritability of prostate cancer: a tale of rare variants and common single nucleotide polymorphisms
Annals of Translational Medicine
2016;
4
(10)
:206
.
(25 May 2016)
Probing personalized genetic platforms for novel molecular clues for circadian chronotype
Annals of Translational Medicine
2016;
4
(10)
:207
.
(25 May 2016)
Letter to the Editor
Dosimetry for photobiomodulation therapy: response to Sommers et al
Annals of Translational Medicine
2016;
4
(10)
:208
.
(25 May 2016)
Disclosure:
1. The series “State of the Art in Diagnostics of the Acute Coronary Syndrome” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Giuseppe Lippi and Gianfranco Cervellin served as the unpaid Guest Editors for the series.
2. The series “Big-data Clinical Trial Column” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.
